I think there needs to be a balance between fundamental curiosity-driven science and applied science, because we need each other. The fundamental science often goes in unexpected directions and leads to advances that wouldn’t have been made otherwise, and CRISPR is certainly in that category.
—University of California, Berkeley, researcher Jennifer Doudna, Nobel Prize–winning codeveloper of CRISPR gene editing, speaking with the Association of American Medical Colleges about the most pressing issues facing the academic medical community (November 8)
ACROSS 1. Country home to Miombo woodlands |
We found that when researchers report that males and females respond differently to a manipulation such as a drug treatment, 70 percent of the time the researchers have not actually compared those responses statistically at all. In other words, an alarming percentage of claims of sex differences are not backed by sufficient evidence.
—Emory University neuroscientist Donna Maney, in a press release reporting the publication of a recent eLife paper she coauthored analyzing data from dozens of 2019 studies (November 9)